Back
Esperion Therapeutics Vs. Deciphera Pharmaceuticals Industry Stock Comparison
Sell
50
ESPR
Esperion Therapeutics
Last Price:
2.20
Seasonality Move:
-3.78%
Buy
75
DCPH
Deciphera Pharmaceuticals
Last Price:
25.36
Seasonality Move:
15.38%
Sell
50
Esperion Therapeutics (ESPR)
is a Sell
Is Esperion Therapeutics a Buy, Sell or Hold?
- The current Esperion Therapeutics [ESPR] share price is $2.19. The Score for ESPR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ESPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Deciphera Pharmaceuticals (DCPH)
is a Buy
Is Deciphera Pharmaceuticals a Buy, Sell or Hold?
- The current Deciphera Pharmaceuticals [DCPH] share price is $25.36. The Score for DCPH is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- DCPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ESPR Stock Price Chart
What is Esperion Therapeutics's stock price today?
-
The Esperion Therapeutics share price today is $2.19
The current trend is relatively stagnant and ESPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DCPH Stock Price Chart
What is Deciphera Pharmaceuticals's stock price today?
-
The Deciphera Pharmaceuticals share price today is $25.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DCPH is experiencing selling pressure, which indicates risk of future bearish movement.
ESPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 50.5 | Buy |
| Chaikin Money Flow: | 6169777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.85 - 2.41) | Buy |
| Bollinger Bands (100): | (2.05 - 2.73) | Sell |
DCPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.8 | Buy |
| Relative Strength Index (14 RSI): | 85.75 | Buy |
| Chaikin Money Flow: | -1453430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.91 - 24.21) | Buy |
| Bollinger Bands (100): | (13.26 - 19.46) | Buy |
ESPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.13 | Buy |
| 20-day SMA: | 2.02 | Buy |
| 50-day SMA: | 2.29 | Sell |
| 200-day SMA: | 1.82 | Buy |
| 8-day EMA: | 2.12 | Buy |
| 20-day EMA: | 2.14 | Buy |
| 50-day EMA: | 2.24 | Sell |
| 200-day EMA: | 2.26 | Sell |
DCPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.37 | Sell |
| 20-day SMA: | 19.98 | Buy |
| 50-day SMA: | 17.44 | Buy |
| 200-day SMA: | 14.66 | Buy |
| 8-day EMA: | 24.49 | Buy |
| 20-day EMA: | 21.52 | Buy |
| 50-day EMA: | 18.52 | Buy |
| 200-day EMA: | 15.68 | Buy |
Esperion Therapeutics Earnings Growth & ESPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.14 per share, and a decrease next year of $0.23 per share.
Deciphera Pharmaceuticals Earnings Growth & DCPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.53 per share.
Esperion Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Deciphera Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||